Pangaea Ventures
Pangaea Ventures
Type of Funding
Venture Capital
Max Funding
N/A
Region
Federal/National
Application Difficuty
Fairly simple
Processing Time
Slow (A few months)
Province
All Of Canada
Industry
Other.
Funding Goals
Start-up Funding.
Demographic
N/A
Incorporated
No
Contact
info@pangaeaventures.com
1.604.800.0411
Apply For A Loan
Business location – Canada
Monthly Revenue – $10K +
Time in Business – 6 months +
Funds in 24 hours
$10,000 to $800,000
Details
Pangaea Ventures is a Venture Capital firm that invests in early- and growth-stage companies with advanced materials innovation.
It aims to make the world a better place by investing in highly innovative entrepreneurs, operating lean, capital-efficient businesses enabled by breakthroughs in advanced materials.
The firm is focused on maximizing the value we deliver to our partners, investors, and portfolio companies while maintaining the highest standard of integrity.
Eligibility
Early- and growth-stage companies using advanced materials
Similar funding programs
Venture Capital
Eventi Capital Partners (ECP) is a Toronto-based growth capital investment group, specializing in software-as-a-service, Internet infrastructure services and more recently medical devices.
Founded in 2002, Eventi Capital Partners leverages the extensive operational and investment experience of its Managing Partners to enable CEOs to scale their business more predictably.
They invest in passionate entrepreneurs who possess deep domain expertise and are committed to building a scalable company that delivers exceptional value to its customers.
Max Funding N/A
Eventi Capital Partners
Venture Capital
Hans Knapp and Steve Hnatiuk founded Yaletown Partners in 2002. It has its headquarters in Vancouver in British Columbia with an additional office in Calgary in Alberta, Montreal in Quebec, and Toronto in Ontario.
Yaletown Partners prefers to lead or co-lead the investments in its portfolio companies. It typically holds its investments for a period of five to eight years. Yaletown invests in emerging-growth technology companies in Canada that enhance sustainability and productivity for industrial and enterprise customers.
Max Funding $2,500,000.00
Yaletown
Venture Capital
Genesys Capital is focused on building companies in the high-growth sectors of healthcare and biotechnology.
Through its expertise and network, Genesys accelerates the development of commercially viable emerging companies that represent promising biotechnology investment opportunities.
Genesys is one of the largest Canadian-based venture capital firms exclusively focused on the life sciences industry.
Max Funding N/A
Genesys Capital